Article2007

Inflammation, Sleep, Obesity and Cardiovascular Disease.

Michelle A. Miller · Francesco Paolo Cappuccio

233 citations0/0 files storedCurrent Vascular Pharmacology

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Abstract

UNLABELLED: Evidence is emerging that disturbances in sleep and sleep disorders play a role in the morbidity of chronic conditions. However, the relationship between sleep processes, disease development, disease progression and disease management is often unclear or understudied. Numerous common medical conditions can have an affect on sleep. For example, diabetes or inflammatory conditions such as arthritis can lead to poor sleep quality and induce symptoms of excessive daytime sleepiness and fatigue. It has also been suggested that poor sleep may lead to the development of cardiovascular disease for which an underlying inflammatory component has been proposed. It is therefore important that the development and progression of such disease states are studied to determine whether the sleep effect merely reflects disease progression or whether it may be in some way causally related. Sleep loss can also have consequences on safety related behaviours both for the individuals and for the society, for example the increased risk of accidents when driving while drowsy. Sleep is a complex phenotype and as such it is possible that there are numerous genes which may each have a number of effects that control an individual's sleep pattern. This review examines the interaction between sleep (both quantity and quality) and parameters of cardiovascular risk. We also explore the hypothesis that inflammation plays an essential role in cardiovascular disease and that a lack of sleep may play a key role in this inflammatory process. AIM: To review current evidence regarding the endocrine, metabolic, cardiovascular and immune functions and their interactions with regard to sleep, given the current evidence that sleep disturbances may affect each of these areas.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 233 citations exist upstream.

References

2006Short Sleep Duration as a Risk Factor for Hypertension 2004Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk 2005Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes 1999Effects of Sleep and Sleep Deprivation on Catecholamine And Interleukin-2 Levels in Humans: Clinical Implications 2005Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population 1996Ethnicity and variations in the nation's health.

Cited by

2013Sleep duration and all-cause mortality: a critical review of measurement and associations 2009Gender Differences in the Cross-Sectional Relationships Between Sleep Duration and Markers of inflammation: Whitehall II Study 2007Cross-sectional versus Prospective Associations of Sleep Duration with Changes in Relative Weight and Body Fat Distribution 2016Sleep duration and risk of coronary heart disease: A systematic review and meta-analysis of prospective cohort studies 2010A population-based study of reduced sleep duration and hypertension: the strongest association may be in premenopausal women 2013Maternal stress, well-being, and impaired sleep in mothers of children with developmental disabilities: A literature review

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

Imported from OpenAlex (CC0) — nothing here is generated.